Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA new Revision: v3.6.6 appears in the record history, replacing the previous v3.6.5. This update represents a metadata version change to the study record and does not alter the study data or eligibility information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision entry (v3.6.5) was added to the record history, indicating an update to the study record since the previous version (v3.6.4). This reflects an internal metadata update rather than a change to study details.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry, v3.6.4, was added to the Record History, representing the latest update to the study record's versioning.SummaryDifference0.1%

- Check64 days agoChange DetectedRecord history shows the latest revision listed as v3.6.3, replacing the prior v3.6.2. This reflects a minor update to the page's release notes rather than substantive changes to study content.SummaryDifference0.1%

- Check72 days agoChange DetectedA new Revision: v3.6.2 entry was added to the study record history, replacing the previous Revision: v3.6.0. This reflects a lightweight release-note update to the page rather than changes to the study data or core content.SummaryDifference0.1%

- Check86 days agoChange DetectedRecruitment status shows no longer looking for participants. The history also adds Revision: v3.6.0 and removes Revision: v3.5.5 to update the record's version history.SummaryDifference0.4%

Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.